XORTX Therapeutics Inc.

General ticker "XRTX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $2.3M (TTM average)

XORTX Therapeutics Inc. does not follow the US Stock Market performance with the rate: -26.8%.

Estimated limits based on current volatility of 2.3%: low 0.62$, high 0.65$

Factors to consider:

  • Total employees count: 3 as of 2021
  • Current price 14.4% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.74$, 2.18$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.66$, 1.93$]

Similar symbols

Short-term XRTX quotes

Long-term XRTX plot with estimates

Financial data

YTD 2024-12-31
Operating Revenue CA$0.00MM
Operating Expenses CA$3.59MM
Operating Income CA$-3.59MM
Non-Operating Income CA$-1.17MM
R&D Expense CA$0.26MM
Income(Loss) CA$-4.76MM
Profit(Loss)* CA$-6.21MM
Stockholders Equity CA$3.34MM
Assets CA$4.09MM
Operating Cash Flow CA$-3.68MM
Capital expenditure CA$0.04MM
Investing Cash Flow CA$-0.04MM
Financing Cash Flow CA$2.78MM
Earnings Per Share** CA$-2.16

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.